Diabetic retinal disease is envisioned to become the plague of the coming decades with a
steep increase of worldwide diabetes incidence followed by a substantial rise in retinal …

Purpose To review the current therapeutic options for the management of diabetic
retinopathy (DR) and diabetic macular edema (DME) and examine the evidence for …

Background: Diabetic retinopathy is a leading cause of visual impairment in working-age
adults worldwide. Duration of diabetes is a major risk factor associated with the development …

Diabetic macular edema (DME) is the major cause of vision loss in diabetic persons.
Alteration of the blood–retinal barrier is the hallmark of this disease, characterized by …

Diabetic retinopathy is one of the most serious microvascular complications induced by
hyperglycemia via five major pathways, including polyol, hexosamine, protein kinase C, and …

The management of diabetic retinopathy (DR) has evolved considerably over the past
decade, with the availability of new technologies (diagnostic and therapeutic). As such, the …

Vision loss in diabetic retinopathy (DR) is ascribed primarily to retinal vascular abnormalities—
including hyperpermeability, hypoperfusion, and neoangiogenesis—that eventually lead to …

Abstract Purpose of Review Diabetes mellitus is a global epidemic which is growing in
prevalence, and diabetic macular edema (DME) is a leading cause of visual impairment …

Purpose: To evaluate the safety and efficacy of Ozurdex (dexamethasone intravitreal
implant) 0.7 mg in the treatment of diabetic macular edema in vitrectomized eyes. Methods …

Diabetic retinopathy and diabetic macular edema result from chronic damage to the
neurovascular structures of the retina. The pathophysiology of retinal damage remains …